Journal of Crohn's & colitis
-
Randomized Controlled Trial
The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease.
We assessed the effect of ustekinumab on health-related quality of life [HRQOL] in adults with Crohn's disease [CD]. ⋯ Ustekinumab improved HRQOL in patients with moderately to severely active CD.